Idorsia and Roche Join Forces to Develop Cancer Immunotherapy … – Labiotech.eu (blog)
Labiotech.eu (blog) |
Idorsia and Roche Join Forces to Develop Cancer Immunotherapy …
Labiotech.eu (blog) Idorsia and Roche have agreed on a research collaboration, with the big pharma getting exclusive rights to develop and license resultant cancer immunotherapy drugs. Idorsia was formed out of J&J's acquisition of Actelion for €27.9B at the beginning of … Idorsia forms research collaboration with Roche in the field of cancer … |
